查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1182112

细胞因子全球市场规模研究与预测：按细胞因子类型、治疗用途、区域分析，2022-2029 年

Global Cytokine Market Size study & Forecast, by Cytokine Type, Therapeutic Application, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

细胞因子是体内各种细胞释放的细胞信号分子。

细胞因子是调节多种生理和代谢过程的蛋白质，是细胞间通讯的重要手段。 市场受到主要因素的推动，例如伤口管理对细胞因子的需求不断增加以及癌症研究的资金增加。

根据 Globocan 2020，登记了 19,292,789 例新癌症病例。 到 2040 年，这个数字预计将达到 28,887,940。 此外，2022 年 4 月，在美国癌症研究协会 (AACR) 2022 年年会上，开发靶向免疫疗法的临床阶段公司 Sonnet BioTherapeutics Holdings, Inc. 宣布其获得专利的全人白蛋白我们正在展示临床前研究的数据关于绑定候选 SON-1010、SON-1210 和 SON-1410。 然而，高昂的处理成本阻碍了整个 2022-2029 年预测期内的市场增长。

全球细胞因子市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于竞争对手的存在、併购、研究资金的收购以及该地区癌症患病率上升，北美在全球市场份额中处于领先地位。 然而，由于政府研发支出的增加和製药公司的增加，预计亚太地区将成为增长最快的地区。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区划分的细胞因子市场
    • 细胞因子市场：按细胞因子类型分类，2019-2029
    • 细胞因子市场：按治疗用途分类，2019-2029 年
  • 主要趋势
  • 调查方法介绍
  • 调查先决条件

第 2 章全球细胞因子市场定义和范围

  • 调查的目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第 3 章全球细胞因子市场动态

  • 细胞因子市场影响分析 (2019-2029)
    • 市场驱动因素
      • 伤口处理对细胞因子的需求不断扩大
      • 扩大对癌症研究的资助
    • 市场挑战
      • 飙升的治疗费用
    • 市场机会
      • 启动研发活动
      • 增加基于细胞培养的研究活动

第四章全球细胞因子市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的结论和建议
  • 顶级投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球细胞因子市场，按细胞因子类型分类

  • 市场概况
  • 全球细胞因子市场：按细胞因子类型进行性能潜力分析
  • 2019-2029 年按细胞因子类型划分的世界细胞因子市场、估计和预测
  • 细胞因子市场、细分市场分析
    • 肿瘤坏死因子 (TNF)
    • 白细胞介素-Il
    • 干扰素-IFN
    • 表皮生长因子-EGF
    • 其他细胞因子类型

第 7 章全球细胞因子市场：按治疗用途分类

  • 市场概况
  • 全球细胞因子市场：按治疗用途分类的性能和潜力分析
  • 世界细胞因子市场、按治疗用途估计和预测 (2019-2029)
  • 全球细胞因子市场细分分析
    • 癌症
    • 支气管哮喘和气道炎症
    • 关节炎
    • 其他治疗用途

第 8 章全球细胞因子市场：区域分析

  • 细胞因子市场，区域市场概况
  • 北美
    • 美国
      • 按细胞因子类型估算和预测，2019-2029 年
      • 2019-2029 年治疗用途的估计和预测
    • 加拿大
  • 欧洲细胞因子市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区细胞因子市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲细胞因子市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • AstraZeneca plc
      • 主要信息
      • 概览
      • 财务信息（取决于数据可用性）
      • 产品概述
      • 近期趋势
    • GlaxoSmithkline PLC
    • Johnson and Johnson
    • Pfizer Inc.
    • Novartis AG
    • Biocon Limited
    • Amgen Inc.
    • Sanofi SA
    • UCB S.A
    • AbbVie Inc.

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Cytokine Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2022-2029. Cytokines are cell signalling molecules that are released by various bodily cells. Cytokines are proteins that regulate a variety of physiological and metabolic processes and serve as a vital form of cell contact. The market is majorly driven by key factors such as the growing demand for cytokines for wound management and growing funding for cancer-based research.

According to Globocan 2020, 19,292,789 new cancer cases were registered. By 2040, this number is anticipated to reach 28,887,940. Additionally, in April 2022, at the American Association for Cancer Research (AACR) Annual Meeting 2022, Sonnet BioTherapeutics Holdings, Inc., a clinical-stage firm developing targeted immunotherapeutic medicines, presented data from preclinical research on the company's patented Fully Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410. However, high costs for Therapy stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cytokine Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the global market shares owing to the presence of competitors, mergers, acquisitions and research funding and the rising prevalence of cancer in the region. However, Asia Pacific is expected to be the fastest growing region owing to growing research and development funding from the government and an increasing number of pharmaceutical manufacturers.

Major market players included in this report are:

AstraZeneca plc

GlaxoSmithkline PLC

Johnson and Johnson

Pfizer Inc.

Novartis AG

Biocon Limited

Amgen Inc.

Sanofi SA

UCB S.A

AbbVie Inc.

Recent Developments in the Market:

  • In July 2020, Derm-Biome Pharmaceutical and Pan-Biome Pharmaceutical stated that they had secured a pre-seed investment of US$ 500,000 to create drugs for the treatment of chronic inflammatory illnesses, including cytokines that reduce inflammation.
  • A contract for the development and production of the medication Lenzilumab was signed in January 2021 by Emergent BioSolutions and Humanigen. This medication is intended to both prevent and treat an immunological hyper-reaction to the cytokine storm.

Global Cytokine Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Cytokines type, Therapeutics Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cytokines Type:

Tumor Necrosis Factor-TNF

Interleukins-Il

Interferons-IFN

Epidermal Growth Factor-EGF

Other Cytokine Types

By Therapeutic Application:

Cancer

Asthma and Airway Inflammation

Arthritis

Other Therapeutic Applications

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Cytokine Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Cytokine Market, by Cytokine Type, 2019-2029 (USD Billion)
    • 1.2.3. Cytokine Market, by Therapeutic Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cytokine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cytokine Market Dynamics

  • 3.1. Cytokine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing demand for cytokines for wound management
      • 3.1.1.2. Growing funding for cancer-based research
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Costs for Therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing research and development activities
      • 3.1.3.2. Growing cell culture-based research activities

Chapter 4. Global Cytokine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cytokine Market, by Cytokine Type

  • 6.1. Market Snapshot
  • 6.2. Global Cytokine Market by Cytokine Type, Performance - Potential Analysis
  • 6.3. Global Cytokine Market Estimates & Forecasts by Cytokine Type 2019-2029 (USD Billion)
  • 6.4. Cytokine Market, Sub Segment Analysis
    • 6.4.1. Tumor Necrosis Factor-TNF
    • 6.4.2. Interleukins-Il
    • 6.4.3. Interferons-IFN
    • 6.4.4. Epidermal Growth Factor-EGF
    • 6.4.5. Other Cytokine Types

Chapter 7. Global Cytokine Market, by Therapeutic Application

  • 7.1. Market Snapshot
  • 7.2. Global Cytokine Market by Therapeutic Application, Performance - Potential Analysis
  • 7.3. Global Cytokine Market Estimates & Forecasts by Therapeutic Application 2019-2029 (USD Billion)
  • 7.4. Cytokine Market, Sub Segment Analysis
    • 7.4.1. Cancer
    • 7.4.2. Asthma and Airway Inflammation
    • 7.4.3. Arthritis
    • 7.4.4. Other Therapeutic Applications

Chapter 8. Global Cytokine Market, Regional Analysis

  • 8.1. Cytokine Market, Regional Market Snapshot
  • 8.2. North America Cytokine Market
    • 8.2.1. U.S. Cytokine Market
      • 8.2.1.1. Cytokine Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Therapeutic Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Cytokine Market
  • 8.3. Europe Cytokine Market Snapshot
    • 8.3.1. U.K. Cytokine Market
    • 8.3.2. Germany Cytokine Market
    • 8.3.3. France Cytokine Market
    • 8.3.4. Spain Cytokine Market
    • 8.3.5. Italy Cytokine Market
    • 8.3.6. Rest of Europe Cytokine Market
  • 8.4. Asia-Pacific Cytokine Market Snapshot
    • 8.4.1. China Cytokine Market
    • 8.4.2. India Cytokine Market
    • 8.4.3. Japan Cytokine Market
    • 8.4.4. Australia Cytokine Market
    • 8.4.5. South Korea Cytokine Market
    • 8.4.6. Rest of Asia Pacific Cytokine Market
  • 8.5. Latin America Cytokine Market Snapshot
    • 8.5.1. Brazil Cytokine Market
    • 8.5.2. Mexico Cytokine Market
  • 8.6. Rest of The World Cytokine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. AstraZeneca plc
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. GlaxoSmithkline PLC
    • 9.2.3. Johnson and Johnson
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Novartis AG
    • 9.2.6. Biocon Limited
    • 9.2.7. Amgen Inc.
    • 9.2.8. Sanofi SA
    • 9.2.9. UCB S.A
    • 9.2.10. AbbVie Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Cytokine Market, report scope
  • TABLE 2. Global Cytokine Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Cytokine Market estimates & forecasts by Cytokine Type 2019-2029 (USD Billion)
  • TABLE 4. Global Cytokine Market estimates & forecasts by Therapeutic Application 2019-2029 (USD Billion)
  • TABLE 5. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Cytokine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Cytokine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Cytokine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Cytokine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Cytokine Market
  • TABLE 70. List of primary sources, used in the study of global Cytokine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Cytokine Market, research methodology
  • FIG 2. Global Cytokine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cytokine Market, key trends 2021
  • FIG 5. Global Cytokine Market, growth prospects 2022-2029
  • FIG 6. Global Cytokine Market, porters 5 force model
  • FIG 7. Global Cytokine Market, pest analysis
  • FIG 8. Global Cytokine Market, value chain analysis
  • FIG 9. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Cytokine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Cytokine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Cytokine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Cytokine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable